MML Investors Services
GPCR icon

MML Investors Services’s Structure Therapeutics GPCR Stock Holding History

MML Investors Services’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
25,601
+11,714
+84% +$518K ﹤0.01% 1800
2026
Q1 		$669K Buy
13,887
+6,062
+77% +$415K ﹤0.01% 2032
2025
Q4 		$544K Buy
+7,825
New +$319K ﹤0.01% 2207

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

MML Investors Services's GPCR Position: Q2 2026 in Review

MML Investors Services increased its Structure Therapeutics (GPCR) stake by 84% in Q2 2026, buying an estimated $518K and bringing the position to 25,601 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1800.

MML Investors Services first reported a position in GPCR in Q4 2025 and has held it in 3 quarters since. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • MML Investors Services held 25,601 shares of Structure Therapeutics worth $1.37M as of Q2 2026.
  • MML Investors Services bought 11,714 Structure Therapeutics shares in Q2 2026, an estimated $518K.
  • Structure Therapeutics made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #1800 holding.
  • MML Investors Services first reported a position in Structure Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.